Macrogen offers support during the early stages of setting up of labs for next-generation gene sequencing panels, including consulting on the panel itself, related equipment and personnel.
Setting up labs for Next-Generation Sequencing panels, or NGS, requires significant efforts. Have a look at the PMG Lab Business Model developed by Macrogen drawing on its years of knowhow. The Model offers a variety of services, including those for clinical NGS panels, sequencing platforms and manpower.
SERVICE
A number of healthcare institutions desire to set up their own lab for gene sequencing panels based on Next-Generation Sequencing techniques, to offer treatments tailored to each individual with the help of precision medicine. But in reality setting up a test lab for NGS panels requires clinical diagnostic test panels built on years of knowhow, highly skilled personnel and certified sequencing platform equipment, not to mention the time and costs associated with securing such resources. Inevitably, only a handful of organizations have succeeded in setting up labs that meet the approval criteria of regulatory authorities to perform NGS panel testing. With over 25 years of experience in gene sequencing, Macrogen can offer customized support in a wide range of areas on your journey to setting up your own lab for NGS panels and precision medicine, with services covering the panel itself to lab personnel, analyses of test results and equipment.
Certification Acquired By Macrogen
In The Clinical Diagnosis Business
Macrogen offers clinical diagnosis services using certified and proven technology.
Key Features And Strengths Of Macrogen’s Cancer Panels
With some of the most cutting-edge gene sequencing technologies in the world and advanced analytical capabilities developed in-house,
Macrogen offers some of the highest quality services available on the market today.
Scope Of Projects To Set Up NGS-based PMG Labs
Macrogen offers services tailored to each client for optimal installation and operation of labs for genetic testing panels using next-generation sequencing techniques.